Brits denied of cancer drugs to save money

NHSAccording to the recently uncovered report Britons are being denied access to drugs crucial in cancer cure in lieu of money.

The report released by the Department of Health pressurizes the Government to speed-up on the proposal to offer 200 million pounds as cancer fund that aims to offer patients drugs which are not currently approved for NHS use.

The method of treatment in case of sun damaged DNA

Sun-Damaged-DNAIn a recent finding, researchers have elaborated how an enzyme functions in atomic level to mend sun-damaged DNA.

It is stated that this type of research can be stone turning measure that will provide future sunburn remedies and skin cancer prevention measures.

Dongping Zhong and his teammates from Ohio State University states that could easily observe the enzyme, called photolyase, which is pumped with a single electron and proton into an injured strand of DNA. These two subatomic particles had later healed the damage.

Shiv Sena launches malaria drive

Shiv-Sena-MalariaShiv Sena has released a motion against malaria.

This drive is targeted at migrant laborers which is added that out of 2,500 construction sites present in Mumbai, just 2% took heed to restrain malaria.

With effect from 1st Aug, the state government in association with Brihanmumbai Municipal Corporation the cards will be offered to more than 3 lakhs laborers and thus keep a tab on their health.

The drive includes a blood test to be done every 15 days and as the census claims malaria-endemic states are Andhra Pradesh, Chattisgarh, Orissa and Uttaranchal.

HD body scanner can spot cardio diseases

HD-Body-ScannerThe advent of latest high-definition body scanner, can aid in providing a better view of the human anatomy thus offering help for heart attacks.

The HD body scanner, is an offering from GE Healthcare, offers pictures of diseased arteries in the heart and at same time locate ailments at an early stage, long before patients experience it, claim doctors at Plymouth's Derriford Hospital.

Mahindra's first quarter net profit up by 40%

Mahindra's first quarter net profit up by 40%India's largest utility vehicles maker Mahindra & Mahindra has announced its first quarter financial results for the fiscal year 2010-11.

According to the company, it has managed to register a significant rise of 40% in its net profit figure in the June quarter against the same quarter in a year ago period. Mahindra & Mahindra has posted a net profit of 5.62 billion rupees for the quarter that ended in 30th June, 2010.

Nasal Spray to cure meningitis

Nasal-SprayThe recent advent of nasal spray vaccine, offers cure for meningitis and pneumonia.

The research team, led by Dr Qibo Zhang, from the University of Liverpool, states that kids can benefit a lot from this spray as it helps combat the bacteria pneumococcus.

The vaccine is known to comprise of a substance called D4Ply, which forms a part of protein produced by nearly all the different types of pneumococcus. The experiments done on the same provide protection against most of the strains.

Pages

News in Focus

The Top 5 Mistakes New Forex Traders Make (and How to Avoid Them)

If you’re just starting out in forex, the odds are stacked—not because the market is out to get you, but because many new traders walk in with the wrong mindset.

Kalyan Jewellers Share Price Target at Rs 786: BOB Capital Markets

BOB Capital Markets has upgraded Kalyan Jewellers to BUY from HOLD with a target price of Rs 786, implying about 18% upside from Rs 664.

Tata Steel Share Price Could Reach Rs 230: ICICI Securities

ICICI Securities has retained its BUY call on Tata Steel with a revised sum-of-the-parts target of Rs 230, implying 24% upside from Rs 185 over 12 months.

Pricol Share Price Target at Rs 935: Axis Securities

Axis Securities has kept its BUY call on Pricol Ltd with an unchanged target price of Rs 935, about 28% above the Nov. 5 closing price of Rs 728.

Mahindra & Mahindra Share Price Target at Rs 4,387: BOB Capital Markets

BOB Capital Markets has retained its BUY rating on Mahindra & Mahindra but trimmed its target price to Rs 4,387 from Rs 4,530, still implying about 40% upside from the Rs 3,128 market price.

ICICI Securities has maintained its BUY rating on Swiggy but cut its target price to Rs 400 from Rs 520, still implying about 90% upside from the Rs 211 market price.